Spin outs - MRC e-Val 2010
Spin out companies founded on MRC research have a significant impact on the UK economy through employment, provision of new products and technologies, and direct investment into the UK. They also play a key role in improving people’s health and wellbeing by developing innovative drugs and therapies; securing financial backing and working with pharmaceutical companies to drive their discoveries into the clinic.
MRC e-Val figures show that MRC-supported research has led to the creation or growth of 66 companies, 35 of which have been formed since 2006. It is estimated that these companies have created over 400 highly skilled jobs.
This section updates the list of companies connected to MRC research with spin outs reported in 2010, reviews the status of these companies and highlights some of their notable successes to date. It also includes examples of licensing-out agreements and scientific advisory input to industry.
